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Methods: Translatability assessments of the US English version of the IBS-D 
PRO were performed by experienced PRO translators who were native speakers 
of each target language and currently residing in-country. Languages included: 
Chinese (China); Dutch (Netherlands); French (Belgium); German (Germany); 
Japanese (Japan); Polish (Poland); Portuguese (Brazil); Russian (Russia); Spanish 
(Mexico); and Spanish (US). The project team assessed the instrument to identify 
potential linguistic and/or cultural adaptation issues. After the identified issues 
were resolved, the instrument was translated into Spanish (US) and Japanese 
through a process of two forward translations, one reconciled translation, and 
one back translation. The project team reviewed the translated versions before 
the instruments were evaluated by cognitive debriefing interviews (CDIs) with 
samples of five Spanish (US) and five Japanese IBS-D patients. Results: A few 
linguistic and cultural adaptation concerns were identified during the translat-
ability assessment as requiring minor revisions: mainly the presentation of dates/
times and word structure. During the CDIs, two out of five Spanish respondents 
misunderstood the term “bowel movement” to mean only diarrhea in the Spanish 
version. Consequently, the term was changed from “movimiento intestinal” to 
“evacuaciones.” None of the Japanese respondents identified issues with the 
Japanese version. ConClusions: The translatability of the IBS-D PRO instru-
ment into ten target languages was confirmed, with only minor changes made to 
the translations of the instrument. The translation and linguistic validation into 
Spanish (US) and Japanese provide evidence that this instrument can be used in 
multinational trials and clinical settings.
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objeCtives: The haemorrhoidal disease is a frequent and chronic illness. The 
anal fissure is the second reason of proctologic medical visits. At the moment, 
there is only a clinical score measuring the grade of the haemorrhoids, but the 
impact of the disease on the patients’ quality of life is not evaluated. The objec-
tive of this study is to validate a specific questionnaire to evaluate the burden 
of the haemorrhoidal disease and anal fissure (HEMO-FISS) on the patients’ daily 
life. Methods: The questionnaire HEMO-FISS, including 38 questions, has been 
submitted to patients suffering from a haemorrhoidal disease or an anal fissure and, 
consulting a participating proctologist in France during the study period (2012-2014). 
The psychometric properties were evaluated by testing the acceptability, construct 
validity and reliability. A principal component analysis (PCA) using Varimax rota-
tion, a Spearman correlation coefficient with SF-12 and PGWBI and a multi-trait 
analysis (MTA) were conducted to assess the construct validity of the questionnaire. 
The reliability was evaluated using Cronbach’s alpha coefficient (CAC). Backward 
Cronbach alpha curves (BCAC) were drawn. Results: A total of 256 patients were 
included in the study. Following the factor analysis, four dimensions were defined: 
physical disorders, psychology, troubles defecating and sexuality. The number of 
questions was reduced from 38 to 28. Item reduction was based on MTA and BCAC. 
A strong correlation was observed between SF-12 and the dimensions regarding 
physical disorders (with PCS) and psychology (with MCS). The Cronbach’s coef-
ficient (all > 0.7) reflected a good internal consistency of the different dimensions 
of the questionnaire. ConClusions: The questionnaire HEMO-FISS displays good 
properties to evaluate the burden of haemorrhoids and anal fissures. Consecutive 
to this preliminary validation, a graded response model (GRM) will be developed to 
precise the unidimensionality of each dimensions.
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objeCtives: The study focused on a secondary aspect of liver diseases, never 
investigated in Italy so far. The study purpose was in fact to obtain the patients’ 
perception about the role of nutrition during the disease phases and in general for 
liver welfare, with the final aim of understanding the importance given to nutri-
tion by patients and the current disinformation to be possibly tackled. Methods: 
EpaC is the most important Italian NGO for hepatopathic patients. An anonymous 
web-based questionnaire was published on the association website www.epac.it. 
It was composed of multiple choice and open questions investigating the gen-
eral info of the patient, health state, and opinions/perceptions about nutritional 
aspects. Results: 483 patients participated the survey. The profile of participants 
was assessed concerning sex, age, health condition, presence of cirrhosis. Mean age 
was 52.9 (min 24 – max 80), 60% males, 76% HCV-positive, 15% cirrhotic. 99% know 
alcohol can damage the liver and 86% answered that any alcohol quantity is poten-
tially harmful (79% do not assume alcohol and 62% go on after being cured). Besides 
alcohol, other foods believed to be harmful to liver are all fried foods, salami, sugar 
and sweets, meat (in particular red meat), cheeses (above all fat cheeses). Although 
in low percentages, 5% and 13% respectively consider vegetables and fruit as harm-
ful. Moreover, 53% think a vegan/vegetarian diet is essential, but 81% would like to 
have a specialist nutritional advice. ConClusions: Considering that nutritional 
aspects are important in everybody’s life, they are particularly relevant in case of 
liver disease. The results shown express patients’ degree of knowledge about these 
aspects and highlights that a certain disinformation is widespread. The results 
also point out liver-suffering patients’ need to receive clinicians’ evidence-based 
advice/information on nutrition and lifestyle as part of the routine counselling 
and to develop an educational campaign on nutrition for hepatopathic patients.
severity*10%risk”:0.355; coef.“moderate severity *10% risk”:0.112; coef.“severe sever-
ity *10% risk”:-0.246; coef.“mild severity *40% risk”: 0.165; coef.”moderate severity 
*40% risk”:-0.116; coef.“severe severity *40% risk”: -0.271. ConClusions: The DCE 
could prove that the included hepatitis C patients have different preferences with 
respect to the probability of risk relative to the severity of different side-effects. In 
all significant characteristics the dominance for less severity and less risk could be 
proven and both aspects were taken into account when making treatment decisions. 
For the first time compound side-effect attributes have been applied in a preference 
elicitation method and detected corresponding differences within patient prefer-
ence measures.
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objeCtives: Ulcerative colitis (UC) management aims to reduce symptoms 
associated with the disorder as well as inducing and maintaining remission. 
Surgery is typically considered in severe or refractory UC patients who have not 
responded to maximal treatment. This study evaluated HRQL following surgery, 
along with experience and severity of complications, including those experienced 
in the longer-term. Methods: UK adult UC patients (n= 202) who had undergone 
bowel surgery completed an online survey including EQ-5D-5L utility assessment, 
Work Productivity and Activity Impairment (WPAI), Inflammatory Bowel Disease 
Questionnaire (IBDQ), post-surgical complications, and Female Sexual Function 
Index (FSFI) or International Index of Erectile Function (IIEF). Results: Over 58% 
of participants were > 1 year post-surgery. Mean EQ-5D utility for the overall sample 
was 0.74. Mean utility was significantly higher in those who reported no complica-
tions post-surgery than in those who did (0.90 vs 0.71; p< 0.001). The most commonly 
reported symptoms since surgery were increased fatigue (56%), abdominal pain 
(42%), and increased stool frequency (31%). Participants with complications had 
reduced HRQL across bowel symptoms, systemic symptoms, emotional functioning 
and social functioning IBDQ domains. They also reported more work time missed, 
greater impairment while working and greater overall impairment of regular activi-
ties due to UC than those without complications. Of those responding about sexual 
function, FSFI scores for 68% of female participants indicated sexual dysfunction 
and IIEF scores for 52% of male participants indicated at least mild erectile dysfunc-
tion. A marked decrease in utility by IBDQ disease severity was observed: those 
classified as having severe disease had lower scores than those classified as being 
in remission (0.52 vs 0.88). ConClusions: Although surgery for UC is intended 
to be curative, IBDQ and EQ-5D data suggest that HRQL may not return to normal 
levels. These results may be related to severity of ongoing fatigue, bowel and sexual 
function problems.
PGI44
systemAtIc lIterAture revIeW of heAlth-relAteD QuAlIty of lIfe In 
PAtIents receIvInG PArenterAl nutrItIon
Neves C1, Chapman A1, Burden S2, Lal S3, MacCulloch A4
1BresMed, Sheffield, UK, 2University of Manchester, Manchester, UK, 3Salford Royal Foundation 
Trust, Salford, UK, 4Shire, Basingstoke, UK
objeCtives: Short bowel syndrome (SBS) is a rare, complex clinical condition that 
results from loss of intestinal absorptive capacity. Parenteral nutrition (PN) is often 
needed to maintain clinical status in patients with SBS. Teduglutide reduces, and 
in some cases eliminates, patients’ dependency on PN. PN is not exclusively used 
in patients with SBS and, since robust utility data is often difficult to collect for rare 
conditions due to limited patient numbers, a wider body of published literature 
reporting a link between PN and health-related quality of life (HRQL) was consid-
ered. We assessed if an acceptable body of evidence was available to determine the 
HRQL impact associated with the use of PN that could support an assessment of 
the potential impact of reduced PN using teduglutide. Methods: Searches were 
performed using MEDLINE, MEDLINE In-Process and Cochrane Library. Additionally, 
hand searches were performed at targeted conferences. Of 2,724 studies screened, 
76 met the inclusion criteria: adults receiving PN for longer than 6 months and 
reported utilities or other HRQL data. Results: Patients receiving PN were shown 
to have lower HRQL than the general population. HRQL was shown to increase 
at initiation of PN, compared to the pre-PN state. However, discontinuation of PN 
and intestinal transplantation (ITx) were associated with further improvements in 
HRQL. Trends associating increased number of PN complications, PN volume and 
PN frequency with lower HRQL were also identified. ConClusions: Improvements 
in HRQL achieved by discontinuing PN and ITx suggest that weaning patients with 
SBS off PN could increase HRQL. These, along with results of an ongoing vignette 
study in patients with SBS, may allow quantification of the HRQL associated with 
the use of teduglutide in SBS.
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objeCtives: Following the 2009 FDA Guidance, a new PRO instrument was devel-
oped to support endpoints in multinational clinical trials assessing IBS with diar-
rhea (IBS-D) symptom severity. Our objective was to assess the translatability of 
the IBS-D PRO instrument into ten languages, and subsequently perform a cultural 
adaptation/linguistic validation of the questionnaire into US Spanish and Japanese.] 
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Patients with stoma evaluated their life quality only with 42.33 points from the 
overall 80. ConClusions: Patients with intestinal diseases are defatigable, and 
have abdominal problems frequently. In case of ulcerative colitis the burden of 
disease is higher, life quality is less favourable. Stoma negatively affects life qual-
ity. The residence is significantly affected by the disease burden and quality of life.
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objeCtives: Chronic Hepatitis C Virus (HCV) infection negatively impacts the 
patient’s quality of life. Interferon (IFN) based therapy has been the standard of 
care for many years yet antiviral therapy of HCV has rapidly evolved since the 
introduction of direct acting antivirals (DAA). This report is based on Turkish Mosaic 
Study. The objective is to characterize patients with chronic HCV and assess the 
impact of IFN-containing treatment on health related quality of life, work related 
productivity and activities of daily living and health care utilization. Methods: 
MOSAIC is an international prospective multicenter observational study that is 
conducted in 20 countries. Consecutive patients with chronic HCV who initiated an 
IFN based treatment within 12 weeks were followed for 48 weeks. Patient charac-
teristics, co-morbidities, treatment history, HCV genotype and clinical status were 
recorded. The response type recorded for previous treatment as null response, 
relapse, discontinued and partial response. Results: Ninety one of 152 patients 
were treatment naïve, and the 61 were treatment experienced. Relapse was the 
dominating response type (50%). GT1 patient ratio was 65,8%, non GT1 patient was 
5,9%, and 28% of patients were unknown at the date of the report. 42.8% of patients 
were male, the mean age was 55.1 . The physicians have not recommended treat-
ment for 73.6% of patiens, and 16.4% of patients rejected the treatment. The leading 
reasons for physicians and the patients were “waiting for IFN-free treatment option” 
is followed by “presumed tolerabilty issue”. ConClusions: IFN based therapy 
has been the standard of care for CHC infection for many years yet the antiviral 
treatment paradigm of HCV has rapidly evolved since the introduction of IFN-free 
direct acting antivirals. Higher efficacy with less side effects seems to improving 
the standard of care.
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objeCtives: This is the first study to assess the diagnostic and therapeutic man-
agement of moderate-to-severe IBS-C in six European countries (France, Germany, 
Italy, Spain, Sweden and UK). Here we present the diagnosis and management 
results from Germany. Methods: Observational 12-month study (6 months ret-
rospective and 6 months prospective) in patients diagnosed with IBS-C (Rome-III 
criteria) in the last five years and moderate-to-severe disease severity at inclusion 
(IBS-Symptom Severity Scale (IBS-SSS) score ≥ 175). One of the main objectives was 
to determine healthcare resource utilisation (HRU) and costs prior to and after 
an active phase of the disease. Results: 102 patients were included (43% severe, 
mean age [±SD] 47.6±18.1 years old, 83.3% female). Mean time since diagnosis: 
4.6±8.4 years; mean symptom duration: 15.0±16.9 years. Diagnostic procedures 
since the onset of symptoms were highly variable: the most common were colo-
noscopies(78.4%), blood tests (65.7%), and abdominal ultrasounds(62.7%). The main 
associated comorbidities were insomnia(31.4%), hypertension(28.4%), chronic pain 
(27.5%), depression(27.5%), and gastroesophageal reflux disease (GERD; 27.5%). 
66.7% of patients had an average of 4.0±2.5 diagnostic tests during follow-up and 
71.6% took prescription drugs (54.9% for IBS-C). The most common medication 
groups were laxatives (35.6%), prokinetics (23.3%), antispasmodics (15.1%), and 
analgesics (11.0%). Overall, 69.6% of patients took non-prescription drugs for their 
IBS-C (32.4% laxatives and 19.6% herbal medicine) and 27.5% of patients sought 
complementary therapies. Overall, improvement in symptom severity (IBS-SSS 
total score±SD) was observed between baseline (288.3±78.8) and the 6-month visit 
(228.1±9.1). ConClusions: Patients with moderate-to-severe IBS-C often remain 
undiagnosed for over 10 years and undergo a variety of diagnostic procedures. 
Chronic comorbidities are frequent. Despite a high use of both prescription and 
non-prescription drugs, mean symptom severity did improve but remained “mod-
erate” overall.
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objeCtives: Assess clinical characteristics and patterns of care among patients 
with G1 Hepatitis C virus (HCV) in EU. Methods: A multi-center retrospective 
chart-review study of HCV patients was conducted in the EU (France/Germany/
Italy/Spain/UK) in 4Q2014 to collect de-identified data on diagnosis, clinical 
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objeCtives: To assess the impact of irritable bowel syndrome with constipation 
(IBS-C) and chronic constipation (CC) on health-related quality of life (HRQOL), 
work and daily activity among US commercially-insured patients. Methods: 
Consenting survey-eligible patients ≥ 18 years identified from the HealthCore 
Integrated Research Database completed a cross-sectional survey. IBS-C cases that 
had ≥ 1 IBS claim and either ≥ 2 constipation claims or ≥ 1 constipation claim and 
≥ 1 constipation-related pharmacy claim and CC cases that had ≥ 2 constipation 
claims ≥ 90 days apart or ≥ 1 constipation claim and ≥ 1 constipation-related phar-
macy claim ≥ 90 days apart were included. Controls were matched on age, gender, 
region, plan type and insurance status. Only cases meeting and controls not meeting 
modified Rome III criteria completed the survey. Short Form-12 v2 physical com-
ponent summary (PCS) and mental component summary (MCS) [range: 0–100; US 
normative mean= 50]) and EuroQol-5D (EQ-5D; range: 0= death to 1= perfect health) 
assessed HRQOL. Work Productivity and Activity Impairment Questionnaire (General 
Health version) assessed absenteeism, presenteeism and daily activities (higher 
percentages indicate greater impairment). Indirect costs were calculated based on 
overall work productivity loss (absenteeism+presenteeism) using the human capi-
tal method. Results: Among 354 respondents (177 IBS-C/CC cases, 177 controls; 
mean age 46±15 years; 86% female; 66% employed), mean PCS and MCS scores 
were lower for cases versus controls (mean differences: 8.9 (p< 0.01), 6.8 (p< 0.01), 
respectively). EQ-5D mean utility score was lower among cases versus controls 
(0.7 versus 0.9; p< 0.01). Cases also had greater overall work productivity loss (28% 
versus 12%; p< 0.01) and activity impairment (39% versus 15%; p< 0.01). Estimated 
indirect costs were $108 higher per employed respondent/week for cases versus 
controls (p< 0.01). ConClusions: IBS-C/CC patients reported lower HRQOL and 
greater impairments in work and daily activity compared with matched controls. 
Treatments that effectively manage IBS-C/CC symptoms may improve these out-
comes in IBS-C/CC patients.
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objeCtives: Liver diseases (LDs) can reduce health-related quality-of-life (HRQoL), 
with an important impact on the burden of LDs. Our aim was to analyze the 
impact of the major LDs on EQ-5D Visual Analogue Scale (VAS) and utility-index 
(UI) through different regression models, using HRQoL of the general population 
as a reference. Methods: HRQoL data were measured using the EQ-5D-3L in a 
sample of patients with 9 major LDs enrolled during 2011-2012 in a multicenter 
study conducted in the most populated region of Italy, Lombardy. Such data 
were added to those recorded in 2013 on a representative sample of Lombardy 
general population. Relationships between the outcomes of interest (VAS and UI) 
and LDs were explored through ordinary least squares (OLS) and Tobit regression, 
that accounts for ceiling effect, adjusting for age and gender. Goodness-of-fit was 
assessed through R2 (OLS) and pseudo-R2(Tobit). Results: The sample included 
9,817 subjects (3,017 with LDs). OLS and Tobit regressions performed similarly on 
VAS (R2:0.13,pseudo-R2:0.12) and estimated the largest and significant HRQoL reduc-
tion in patients with decompensated cirrhosis (DC), followed by those with autoim-
mune hepatitis (AIH) and hepatocellular carcinoma (HCC). As for UI, the Tobit model 
performed better than OLS regression (R2:0.11,pseudo-R2:0.15), with the highest 
decrease estimated in patients with DC, followed by those with HCC and compen-
sated cirrhosis. ConClusions: The Tobit model performed slightly better than OLS 
regression on the UI, but not on VAS, maybe due to a stronger ceiling effect in UI. 
This distributional difference mirrors different data-generation mechanisms: UI is 
derived from the EQ-5D-3L domains, while VAS is reported by patients. Therefore, 
VAS and UI might capture different aspects of HRQoL, as supported by our results, 
that show how the same LD can be differently associated with VAS and UI (e.g.: AIH 
seemed to have an impact on VAS only, while HCC on UI only).
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objeCtives: The number of patients over 19 years with registered inflammable 
bowel disease which has non-infectious origin is duplicated in the last 16 years (KSH 
2013). Our aim is to get a picture about the different dimensions of life quality in the 
course of the chronic disease. Methods: Cross-sectional, quantitative examina-
tion was carried out between 15.07.2014 and 31.12.2014 at the Clinical Centre of the 
University of Pécs. Patients with M Crohn and ulcerative colitis between the age of 
18 and 46 were selected with non-randomized, convenience sampling method. For 
data collection we used standard questionnaires (Illness Intrusiveness Rating Scale, 
IBDQ, Coloplast life quality questionnaire) and questions about demographic data 
(N= 103). We used Microsoft Excel 2013 software to carry out descriptive statistics, 
two-sample t-test and χ 2- test (p< 0.05). Results: The age of the patients were 
between 31.03±8.18. Illness Intrusiveness Rating Scale (the effect of the disease 
on role efficiency) was evaluated more unfavourable by the patients with ulcera-
tive colitis (p< 0.05). Average life quality is not affected by gender (p= 0.21), marital 
status (p= 0.15), te type of the disease (p= 0.77), and employment status (p= 0.75). 
